Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Pancreatic fistula

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    17 result(s) found for: Pancreatic fistula. Displaying page 1 of 1.
    EudraCT Number: 2013-000639-29 Sponsor Protocol Number: ABCSG_P00 Start Date*: 2013-03-27
    Sponsor Name:ABCSG (Austrian Breast & Colorectal Cancer Study Group)
    Full Title: A prospective, open, randomized, academic phase II, two-arm trial evaluating the effect of fibrin-coated collagen (TachoSil®) on postoperative pancreatic leakage and fistula formation from the panc...
    Medical condition: pancreatic surgery - evaluation of the effect of fibrin-coated collagen
    Disease: Version SOC Term Classification Code Term Level
    18.0 10017947 - Gastrointestinal disorders 10049192 Pancreatic fistula PT
    18.0 100000004863 10050457 Pancreatic anastomotic leak LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2016-001673-32 Sponsor Protocol Number: P150915 Start Date*: 2016-10-19
    Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
    Full Title: PREVENTION OF POSTOPERATIVE PANCREATIC FISTULA BY SOMATOSTATIN (PREFIPS)
    Medical condition: Patients candidate for pancreatic surgery (pancreaticoduodenectomy or distal pancreatectomy with or without splenectomy).
    Disease: Version SOC Term Classification Code Term Level
    19.0 10017947 - Gastrointestinal disorders 10049192 Pancreatic fistula PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2018-004239-63 Sponsor Protocol Number: NL68231.078.18 Start Date*: 2019-08-23
    Sponsor Name:Erasmus MC
    Full Title: Botulinum toxin (BOTOX®) to prevent post-operative pancreatic fistula in patients who undergo distal pancreatectomy. PROFIT study.
    Medical condition: Post-operative pancreatic fistula
    Disease: Version SOC Term Classification Code Term Level
    20.0 10017947 - Gastrointestinal disorders 10049192 Pancreatic fistula PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2009-014862-25 Sponsor Protocol Number: a004c Start Date*: 2010-01-22
    Sponsor Name:Helsinki University Central Hospital
    Full Title: Dexmedetomidine vs placebo in ERCP sedation
    Medical condition: ERCP(Endoscopic retrograde cholangiopancreatography)
    Disease: Version SOC Term Classification Code Term Level
    12.1 10049192 Pancreatic fistula LLT
    12.1 10052108 Pancreatic duct stone LLT
    12.1 10033634 Pancreatic therapeutic procedures HLT
    12.1 10033615 Pancreatic cyst LLT
    12.1 10033616 Pancreatic disorder LLT
    12.1 10033635 Pancreatic pseudocyst LLT
    12.1 10052377 Pancreatic sphincterotomy LLT
    12.1 10015115 ERCP LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-012994-37 Sponsor Protocol Number: TACO1 Start Date*: 2009-12-13
    Sponsor Name:UNIVERSITA` CAMPUS BIOMEDICO
    Full Title: RANDOMISED PROSPECTIVE TRIAL: PREVENTION OF PANCREATIC FISTULA AFTER PANCREATICO-DUODENECTOMY USING BIOLOGICAL SEALANT
    Medical condition: - patients underwent pancreatico-duodenectomy with pancreatico-jejunal anastomosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10042613 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-005714-46 Sponsor Protocol Number: ICH-001-2008 Start Date*: 2009-02-10
    Sponsor Name:ISTITUTO CLINICO HUMANITAS
    Full Title: BIOLOGICALS SUPPORTS STUDY IN RESECTIVE SURGERY OF PANCREATIC
    Medical condition: PANCREATIC DISEASE
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2016-000212-16 Sponsor Protocol Number: HYKS-190116 Start Date*: 2016-04-12
    Sponsor Name:Helsinki University Central Hospital
    Full Title: Hydrocortisone vs. pasireotide in preventing pancreatic fistula and other complications after pancreatic resection - a prospective, randomized, controlled trial
    Medical condition: Patients undergoing pancreatic resection.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: View results
    EudraCT Number: 2020-005483-66 Sponsor Protocol Number: RASTA Start Date*: 2021-11-18
    Sponsor Name:UNIVERSITÀ DEGLI STUDI MILANO BICOCCA
    Full Title: ERAS versus ERAS plus arTificiAl nutrition in open pancreatoduodenectomy (The RASTA trial)
    Medical condition: Periampullary or pancreatic cancer
    Disease: Version SOC Term Classification Code Term Level
    21.1 10042613 - Surgical and medical procedures 10033644 Pancreaticoduodenectomy PT
    20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10061902 Pancreatic neoplasm PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-002461-35 Sponsor Protocol Number: PREBOTPilot Start Date*: 2019-12-06
    Sponsor Name:Ruprecht-Karls-University Heidelberg Medical Faculty represented by Universitätsklinikum Heidelberg and its acting Comm
    Full Title: Monocenter, randomized, controlled, open-label, phase-II clinical trial of PREoperative endoscopic injection of BOTulinum toxin in the sphincter of Oddi to reduce postoperative pancreatic fistula a...
    Medical condition: Elective distal pancreatectomy for any underlying disease
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004865 10013476 Distal pancreatectomy LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2022-003217-11 Sponsor Protocol Number: NL82304.058.22 Start Date*: 2023-02-24
    Sponsor Name:Leiden University Medical Center
    Full Title: Standard versus Pre-emptive Antibiotic Treatment to Reduce the Rate of Infectious Outcomes after Whipple procedure (SPARROW): a multicenter, randomized controlled trial
    Medical condition: Pancreatic head malignancy
    Disease: Version SOC Term Classification Code Term Level
    21.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10033614 Pancreatic carcinoma resectable LLT
    21.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10026319 Malignant neoplasm of pancreatic duct LLT
    27.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10008597 Cholangiocarcinoma resectable LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2017-002036-17 Sponsor Protocol Number: NL61961.078.17 Start Date*: 2018-03-06
    Sponsor Name:Erasmus Medical Center
    Full Title: THE (COST)EFFECTIVENESS OF NEOADJUVANT FOLFIRINOX VERSUS NEOADJUVANT GEMCITABINE BASED CHEMORADIOTHERAPY AND ADJUVANT GEMCITABINE FOR (BORDERLINE) RESECTABLE PANCREATIC CANCER
    Medical condition: (borderline) resectable pancreatic cancer
    Disease: Version SOC Term Classification Code Term Level
    21.0 100000004864 10033602 Pancreatic adenocarcinoma resectable LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2021-006991-18 Sponsor Protocol Number: 2020/0423/HP Start Date*: 2023-04-21
    Sponsor Name:CHU de Rouen
    Full Title: Postoperative anti-infective strategy following pancreaticoduodenectomy in patients with preoperative biliary stent
    Medical condition: Patients with preoperative biliary stent treated by pancreaticoduodenectomy
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004864 10073866 Tumor of hepatopancreatic ampulla LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2012-003669-17 Sponsor Protocol Number: NEOPA Start Date*: 2013-12-17
    Sponsor Name:University Medical Center Hamburg-Eppendorf
    Full Title: Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma (NEOPA).
    Medical condition: Non-metastasized, adenocarcinoma of the pancreatic head/uncinate process or body of pancreas that was treated with extended pancreatic head/body resection larger than 2 cm in size (≥cT2) and/or in ...
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004864 10033602 Pancreatic adenocarcinoma resectable LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2013-004200-19 Sponsor Protocol Number: PRICKLE Start Date*: 2014-06-13
    Sponsor Name:Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge
    Full Title: Pancreatic Resectability in Cancers with Known Limited Extension (PRICKLE) - A single-centre phase 2a study of Gemcitabine plus Nab-paclitaxel for borderline unresectable locally advanced pancreati...
    Medical condition: Locally advanced pancreatic cancer
    Disease: Version SOC Term Classification Code Term Level
    17.0 100000004864 10033606 Pancreatic cancer non-resectable LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2012-003181-40 Sponsor Protocol Number: 2012-249 Start Date*: 2012-12-11
    Sponsor Name:Foundation for Liverdisease
    Full Title: Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: a multicentre randomized phase III clinical trial
    Medical condition: patients with resectable or borderline resectable pancreatic cancer.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2018-002852-34 Sponsor Protocol Number: S61508 Start Date*: 2020-02-10
    Sponsor Name:UZLeuven
    Full Title: Progression-free Survival after Minimally Invasive Surgical Microwave Ablation plus Durvalumab (MEDI4736) and Tremelimumab for Unresectable Non-metastatic Locally Advanced Pancreatic Cancer. MIMIPA...
    Medical condition: Unresectable Locally Advanced Non Metastatic Pancreatic Cancer
    Disease: Version SOC Term Classification Code Term Level
    21.0 100000004864 10033606 Pancreatic cancer non-resectable LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2018-000415-25 Sponsor Protocol Number: PROSPER Start Date*: 2018-08-10
    Sponsor Name:University Hospital Heidelberg
    Full Title: PANCREATIC RESECTION WITH PERIOPERATIVE OFF-LABEL STUDY OF PROPRANOLOL AND ETODOLAC – A PHASE II RANDOMIZED TRIAL
    Medical condition: Patients with pancreatic carcinoma treated by pancreatoduodenectomy.
    Disease: Version SOC Term Classification Code Term Level
    21.0 100000004865 10033659 Pancreatoduodenectomy LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat May 10 01:18:24 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA